Explore AI’s evolution, challenges, and breakthroughs at RSNA23. Leaders, including Connie Lehman, MD, PhD, Etta D. Pisano, MD, and Fredrik Strand, MSc, MD, PhD, delve into clinical implementation challenges, cutting-edge research outcomes, and regulatory…
Continue Reading
Paige redefines cancer detection with a groundbreaking AI derived from the Virchow Pathology Foundation Model. This innovation spans over 17 tissue types, including rare tumors and metastatic deposits. By leveraging a vast repository of…
Continue Reading
What You Should Know:
– Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
– Under the terms of the agreement, Veracyte will pay $70…
Continue Reading
Doctors at Englewood Health in New Jersey are using the Ion endoluminal system from Intuitive Surgical to take tissue biopsies from the hard-to-reach outer third of the lung to identify early-stage lung cancer.WHY IT…
Continue Reading
Lunit’s acquisition of Volpara at AUD 1.15 per share marks a pivotal move in cancer diagnostics. The Scheme Implementation Agreement targets Volpara’s AI-enabled solutions, expanding Lunit’s global presence. Volpara’s 100 million mammogram images promise…
Continue Reading
What You Should Know:
– South Korean AI leader Lunit has announced its intention to acquire Volpara, a global pioneer in AI-powered cancer detection software, in a landmark deal worth AUD 292M (USD 193M)….
Continue Reading
RSNA 2023 showcased Koning Health’s groundbreaking Koning Vera Breast CT, revolutionizing breast cancer detection with its unparalleled 3D imaging and biopsy capabilities. The event underscored the urgency for early cancer detection, emphasizing KBCT’s ability…
Continue Reading
The UEF Cancer AI team launched a challenge for estimating breast density from mammograms. Addressing limitations in existing tools, the challenge seeks innovative deep-learning architectures. Participants work with a dataset of 569 mammogram images,…
Continue Reading
What You Should Know:
– Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer.
– This…
Continue Reading
Hologic’s RSNA 2023 unveiling presented Genius AI Detection 2.0, a groundbreaking technology slashing false-positive markings by 70%. Alongside SecurView 12.0, it streamlines lesion correlation for expedited reviews. Erik Anderson emphasized their commitment to enhancing…
Continue Reading
